文献速递中医内科中药与中成药合理使用中医康复

COVID-19恢复期三证六中成药研究

The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.
PubMed 文献 · Chin Med · 2021-06-07

针对COVID-19恢复期患者常见的心肺功能、睡眠障碍和消化功能异常,研究者于2020年4月10日启动了三证六中成药随机双盲安慰剂对照多中心临床试验。结果显示金水宝片和生脉饮口服液显著改善心肺功能,舒眠胶囊(而非逍遥胶囊)显著改善睡眠障碍,香砂六君丸和潞党参口服液显著改善消化功能,为恢复期 sequelae 治疗提供了高质量证据。

要点

  • 金水宝片和生脉饮口服液可显著改善恢复期患者心肺功能。
  • 舒眠胶囊显著改善睡眠障碍,逍遥胶囊未见显著效果。
  • 香砂六君丸和潞党参口服液显著改善消化功能。

核心结论

  • 六种中成药中,金水宝片、生脉饮口服液、舒眠胶囊、香砂六君丸和潞党参口服液分别对恢复期心肺功能、睡眠和消化异常有显著改善。

研究设计与样本

  • 三证六中成药随机、双盲、安慰剂对照、多中心临床试验,于2020年4月10日启动,针对COVID-19恢复期患者。

主要发现

  • 金水宝片和生脉饮口服液显著改善恢复期患者心肺功能。
  • 舒眠胶囊显著改善睡眠障碍,而逍遥胶囊未见显著改善。
  • 香砂六君丸和潞党参口服液显著改善消化功能。

临床怎么用

  • 恢复期心肺功能异常可考虑金水宝片或生脉饮口服液。
  • 恢复期睡眠障碍可考虑舒眠胶囊,逍遥胶囊可能不适用。
  • 恢复期消化功能异常可考虑香砂六君丸或潞党参口服液。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), first broke out in Wuhan, China, in 2019. SARS-CoV-2 develops many types of mutations (such as B.1.1.7), making diagnosis and treatment challenging. Although we now have a preliminary understanding of COVID-19, including pathological changes, clinical manifestations, and treatment measures, we also face new difficulties. The biggest problem is that most COVID-19 patients might face sequelae (e.g., fatigue, sleep disturbance, pulmonary fibrosis) during the recovery phase. We aimed to test six Chinese patent medicines to treat three major abnormal symptoms in COVID-19 patients during the recovery phase, including cardiopulmonary function, sleep disturbance, and digestive function. We launched the "three syndromes and six Chinese patent medicines" randomized, double-blind, placebo-controlled, multicenter clinical trial on April 10, 2020. The results showed that Jinshuibao tablets and Shengmaiyin oral liquid significantly improved the cardiopulmonary function of recovering COVID-19 patients. Shumian capsules, but not Xiaoyao capsules, significantly improved patients' sleep disorders. This might be because the indication of Xiaoyao capsules is liver qi stagnation rather than psychological or emotional problems. Xiangsha Liujun pills and Ludangshen oral liquid significantly improved digestive function. Our research provides a guideline for treating COVID-19 sequelae in patients during the recovery period based on high-quality evidence.

来源:Chin Med,查看原文。版权归原作者所有。

引用

  1. An X, Duan L, Zhang YH, et al. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin Med. 2021. PMID: 34099015. doi:10.1186/s13020-021-00454-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。